TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
AdvocoTox AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
174
|
176 | |
| Financial expenses |
0
|
0 | |
| Earnings before taxes |
9
|
-4 | |
| EBITDA |
9
|
-4 | |
| Total assets |
59
|
51 | |
| Current assets |
59
|
51 | |
| Current liabilities |
20
|
21 | |
| Equity capital |
35
|
28 | |
| - share capital |
9
|
9 | |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
59.3%
|
54.9% | |
| Turnover per employee |
87
|
88 | |
| Profit as a percentage of turnover |
5.2%
|
-2.3% | |
| Return on assets (ROA) |
15.3%
|
-7.8% | |
| Current ratio |
295.0%
|
242.9% | |
| Return on equity (ROE) |
25.7%
|
-14.3% | |
| Change turnover |
-3
|
-10 | |
| Change turnover % |
-5%
|
-2%
|
-5% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.